Search
for
Sort by
Research 30 of 1000+
- Epidermal Notch signalling: differentiation, cancer and adhesion
- Editor's Picks
- A combination of pyridine‐2, 4‐dicarboxylic acid diethyl ester and resveratrol stabilizes hypoxia‐inducible factor 1‐alpha and improves hair density in female volunteers
- Age-associated thin hair displays molecular, structural and mechanical characteristic changes
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Targeted Inactivation of Gh/Tissue Transglutaminase II
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Behavioural characterization of Vitamin D receptor knockout mice
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Central Opioid Inhibition of Neuroendocrine Stress Responses in Pregnancy in the Rat Is Induced by the Neurosteroid Allopregnanolone
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Contrasting Localization of c-Myc with Other Myc Superfamily Transcription Factors in the Human Hair Follicle and During the Hair Growth Cycle
- The genetics of alopecia areata: What's new and how will it help our patients?
- Intercellular Adhesion Molecule-1 and Hair Follicle Regression
- CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia
- 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Spironolactone
- Author response: Plant Trans-Golgi Network/Early Endosome pH regulation requires Cation Chloride Cotransporter (CCC1)
- Vascular Injury After Deoxycholic Acid Injection
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata